Three months ended March 31, 2023 2022 Net sales $ 8,031 $ 8,829 Operating expenses Cost of sales 4,613 4,826 Selling, general and administrative expenses 1,705 1,882 Research, development and related expenses 472 480 Total operating expenses 6,790 7,188 Operating income 1,241 1,641 Other expense (income), net 52 38 Income before income taxes 1,189 1,603 Provision for income taxes 210 302 Income of consolidated group 979 1,301 Income (loss) from unconsolidated subsidiaries, net of taxes 2 2 Net income including noncontrolling interest 981 1,303 Less: Net income (loss) attributable to noncontrolling interest 5 4 Net income attributable to 3M $ 976 $ 1,299 Weighted average 3M common shares outstanding – basic 552.7 572.3 Earnings per share attributable to 3M common shareholders – basic $ 1.77 $ 2.27 Weighted average 3M common shares outstanding – diluted 553.2 575.0 Earnings per share attributable to 3M common shareholders – diluted $ 1.76 $ 2.26 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (Millions, except per-share amounts) (Unaudited) 1 -- 1 of 13 -- March 31, 2023 December 31, 2022 ASSETS Current assets Cash and cash equivalents $ 3,824 $ 3,655 Marketable securities – current 145 238 Accounts receivable – net 4,638 4,532 Inventories 5,306 5,372 Prepaids 558 435 Other current assets 492 456 Total current assets 14,963 14,688 Property, plant and equipment – net 9,247 9,178 Operating lease right of use assets 883 829 Goodwill and intangible assets – net 17,440 17,489 Other assets 4,353 4,271 Total assets $ 46,886 $ 46,455 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 3,012 $ 1,938 Accounts payable 3,130 3,183 Accrued payroll 604 692 Accrued income taxes 268 259 Operating lease liabilities – current 263 261 Other current liabilities 3,279 3,190 Total current liabilities 10,556 9,523 Long-term debt 12,948 14,001 Other liabilities 8,031 8,161 Total liabilities 31,535 31,685 Total equity 15,351 14,770 Shares outstanding March 31, 2023: 551,672,217 December 31, 2022: 549,245,105 Total liabilities and equity $ 46,886 $ 46,455 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) 2 -- 2 of 13 -- Three months ended March 31, 2023 2022 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 1,275 $ 1,011 Cash flows from investing activities: Purchases of property, plant and equipment (475) (424) Purchases and proceeds from sale or maturities of marketable securities and investments – net 86 92 Proceeds from sale of businesses, net of cash sold — 13 Other investing activities 3 56 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (386) (263) Cash flows from financing activities: Change in debt (43) (584) Purchases of treasury stock (29) (773) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 187 164 Dividends paid to shareholders (827) (852) Other financing activities (4) (9) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (716) (2,054) Effect of exchange rate changes on cash and cash equivalents (4) (11) Net increase (decrease) in cash and cash equivalents 169 (1,317) Cash and cash equivalents at beginning of year 3,655 4,564 Cash and cash equivalents at end of period $ 3,824 $ 3,247 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) 3 -- 3 of 13 -- Three months ended March 31, 2023 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 1.2 % (14.9) % (4.5) % (4.9) % Divestitures (1.6) (1.0) (1.0) (1.3) Translation (0.5) (5.4) (4.9) (2.8) Total sales change (0.9) % (21.3) % (10.4) % (9.0) % Three months ended March 31, 2023 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial (6.0) % — % — % (2.9) % (8.9) % Transportation and Electronics (8.0) — (1.0) (3.4) (12.4) Health Care 1.4 — (4.3) (2.7) (5.6) Consumer (6.8) — (0.3) (1.9) (9.0) Total Company (4.9) — (1.3) (2.8) (9.0) (a) Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction. 3M Company and Subsidiaries SALES CHANGE ANALYSIS (a) (Unaudited) -- 4 of 13 -- 3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated”). Effective in the first quarter of 2023, the measure of segment operating performance and segment composition used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income) was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company’s business segments. The changes included the items described below. The financial information presented herein reflects the impact of these business segment reporting changes for all periods presented. Reflecting gains/losses from sale of property, plant and equipment (PPE) and other assets within Corporate and Unallocated Change 3M updated its business segment operating performance measure to reflect all gains/losses from sales of PPE and other assets within Corporate and Unallocated. Previously, certain of these gains/losses were included in 3M’s business segments’ operating performance. Movement of certain businesses between segments The businesses associated with two groups of products (each with approximately $25 million in sales) were realigned with one moving from the Consumer business segment to the Health Care business segment and the other moving from the Health Care business segment to the Consumer business segment. Also effective in the first quarter of 2023, the Consumer business segment re-aligned from four divisions to the following three divisions: Home, Health and Auto Care; Construction and Home Improvement Markets; and Stationery and Office. BUSINESS SEGMENT INFORMATION Three months ended March 31, NET SALES (Millions) 2023 2022 Safety and Industrial $ 2,779 $ 3,051 Transportation and Electronics 2,050 2,340 Health Care 2,010 2,128 Consumer 1,192 1,309 Corporate and Unallocated — 1 Total Company $ 8,031 $ 8,829 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) -- 5 of 13 -- BUSINESS SEGMENT INFORMATION Three months ended March 31, OPERATING INCOME (LOSS) (Millions) 2023 2022 Safety and Industrial $ 601 $ 627 Transportation and Electronics 294 464 Health Care 360 445 Consumer 179 219 Total business segment operating income (loss) 1,434 1,755 Corporate and Unallocated Corporate special items: Net costs for significant litigation (82) (187) Divestiture costs (102) — Total corporate special items (184) (187) Other corporate expense - net (9) 73 Total Corporate and Unallocated (193) (114) Total Company operating income 1,241 1,641 Other expense/(income), net 52 38 Income before income taxes $ 1,189 $ 1,603 Corporate and Unallocated Corporate and Unallocated operating income includes “corporate special items” and “other corporate expense-net”. Corporate special items include net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/ asbestos matters during the chapter 11 bankruptcy period (which began in July 2022) and with PFAS-related other environmental matters. Corporate special items also include divestiture costs, gain/loss on business divestitures, divestiture- related restructuring costs, and Russia exit costs. Divestiture costs include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. Other corporate expense-net includes items such as net costs related to limited unallocated corporate staff and centrally managed material resource centers of expertise costs, corporate philanthropic activity, gains/losses from sales of PPE and other assets, and other net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs and income from transition supply, manufacturing, and service arrangements with Neogen Corporation following the 2022 split-off of 3M's Food Safety business. Items classified as revenue from this activity are included in Corporate and Unallocated net sales. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) -- 6 of 13 -- In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies. Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable. In 2023, 3M changed certain of its non-GAAP measures by adjusting for the results of manufactured PFAS products in arriving at results, adjusted for special items. In the fourth quarter of 2022, 3M recorded a charge for PFAS manufacturing exit costs and included it as an adjustment in arriving at results, adjusted for special items. The 2023 non-GAAP measure change involved expanding the extent of adjustment to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025. This change also impacts other non-GAAP measures such as adjusted free cash flow, adjusted free cash flow conversion and adjusted EBITDA to similarly include relevant special item adjustments for manufactured PFAS products. The information herein reflects the impacts of these changes for all periods presented. This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include: GAAP amounts for which a measure adjusted for special items is also provided: Reasons 3M believes the measure is useful • Net sales (and sales change) Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items • Operating income, segment operating income and operating income margin • Income before taxes • Provision for income taxes and effective tax rate • Net income • Earnings per share Additional non-GAAP measures: • Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance • Adjusted EBITDA and adjusted EBITDA margin Considered in evaluating and managing operations; meaningful in analyses of ongoing underlying operating trends • Net debt Meaningful as indicator of liquidity and measure of capital structure strategy The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) -- 7 of 13 -- Certain amounts adjusted for special items (non-GAAP measures): Three months ended March 31, 2022 (Dollars in millions, except per share amounts) Net Sales Operating Income Operating Income Margin Income Before Taxes Provision for Income Taxes Effective tax rate Net Income Attributab le to 3M Earnings per Diluted Share Safety and Industrial GAAP amounts $ 627 20.6 % Adjustments for special items: Net costs for significant litigation 63 Total special items 63 Adjusted amounts (non-GAAP measures) (b) $ 690 22.6 % Transportation and Electronics GAAP amounts $ 2,340 $ 464 19.8 % Adjustments for special items: Manufactured PFAS products (320) (16) Total special items (320) (16) Adjusted amounts (non-GAAP measures) (b) $ 2,020 $ 448 22.2 % Total Company GAAP amounts $ 8,829 $ 1,641 18.6 % $ 1,603 $ 302 18.8 % $ 1,299 $ 2.26 Adjustments for special items: Net costs for significant litigation — 250 250 25 225 0.39 Manufactured PFAS products (320) (16) (16) (4) (12) (0.02) Total special items (320) 234 234 21 213 0.37 Adjusted amounts (non-GAAP measures) (b) $ 8,509 $ 1,875 22.0 % $ 1,837 $ 323 17.5 % $ 1,512 $ 2.63 Three months ended March 31, 2023 (Dollars in millions, except per share amounts) Net Sales Sales Change Operating Income Operating Income Margin Income Before Taxes Provision for Income Taxes Effective tax rate Net Income Attributab le to 3M Earnings per Diluted Share Earnings per diluted share percent change Safety and Industrial GAAP amounts $ 601 21.6 % Adjustments for special items: Net costs for significant litigation (39) Total special items (39) Adjusted amounts (non-GAAP measures) (b) $ 562 20.2 % Transportation and Electronics GAAP amounts $ 2,050 (12.4) % $ 294 14.4 % Adjustments for special items: Manufactured PFAS products (345) (10) Total special items (345) (10) Adjusted amounts (non-GAAP measures) (b) $ 1,705 (15.6) % $ 284 16.7 % Total Company GAAP amounts $ 8,031 (9.0) % $ 1,241 15.4 % $ 1,189 $ 210 17.7 % $ 976 $ 1.76 (22) % Adjustments for special items: Net costs for significant litigation — 43 43 7 36 0.07 Manufactured PFAS products (345) (10) (10) (3) (7) (0.01) Divestiture costs — 102 102 20 82 0.15 Total special items (345) 135 135 24 111 0.21 Adjusted amounts (non-GAAP measures) (b) $ 7,686 (9.7) % $ 1,376 17.9 % $ 1,324 $ 234 17.7 % $ 1,087 $ 1.97 (25) % (b) These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) -- 8 of 13 -- Full Year 2023 Forecast 2023 adjusted earnings per share (non-GAAP measure)*(b) $8.50 to $9.00 2023 adjusted effective tax rate (non-GAAP measure)*(b) 18 % to 19 % * 3M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”. Three months ended March 31, 2023 Sales Change (a) Organic sales Acquisitions Divestitures Translation Total sales change Total Company (4.9) % — % (1.3) % (2.8) % (9.0) % Remove manufactured PFAS products special item impact (0.7) — — — (0.7) Adjusted total Company (non-GAAP measures) (b) (5.6) % — % (1.3) % (2.8) % (9.7) % Transportation and Electronics (8.0) % — % (1.0) % (3.4) % (12.4) % Remove manufactured PFAS products special item impact (3.3) — (0.1) 0.2 (3.2) Adjusted Transportation and Electronics (non-GAAP measures) (b) (11.3) % — % (1.1) % (3.2) % (15.6) % By Geographic Area Americas 1.2 % — % (1.6) % (0.5) % (0.9) % Remove manufactured PFAS products special item impact (0.8) % — % — % 0.1 % (0.7) % Adjusted Americas (non-GAAP measures) (b) 0.4 % — % (1.6) % (0.4) % (1.6) % Asia Pacific (14.9) % — % (1.0) % (5.4) % (21.3) % Remove manufactured PFAS products special item impact (1.8) % — % — % 0.1 % (1.7) % Adjusted Asia Pacific (non-GAAP measures) (b) (16.7) % — % (1.0) % (5.3) % (23.0) % Europe, Middle East & Africa (4.5) % — % (1.0) % (4.9) % (10.4) % Remove manufactured PFAS products special item impact 0.6 % — % — % (0.1) % 0.5 % Adjusted Europe, Middle East & Africa (non-GAAP measures) (b) (3.9) % — % (1.0) % (5.0) % (9.9) % Full-Year 2023 Forecast Worldwide Sales Change (a) Organic sales Acquisitions Divestitures Translation Total sales change Total Company* (3)% to flat % — % (1)% (2)% to (1)% (6)% to (2)% Remove manufactured PFAS products impact* — % — % — % — % — % Adjusted total Company (non-GAAP measures)* (b) (3)% to flat % (1)% (2)% to (1)% (6)% to (2)% 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) -- 9 of 13 -- Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non- GAAP measures): Three months ended March 31, Major GAAP Cash Flow Categories (dollars in millions) 2023 2022 Net cash provided by (used in) operating activities $ 1,275 $ 1,011 Net cash provided by (used in) investing activities (386) (263) Net cash provided by (used in) financing activities (716) (2,054) Three months ended March 31, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2023 2022 Net cash provided by (used in) operating activities $ 1,275 $ 1,011 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 58 128 Divestiture costs after-tax payment impacts 43 — Divestiture-related restructuring after-tax payment impacts 2 — Manufactured PFAS products impact 13 11 Total adjustments for special items 116 139 Adjusted net cash provided by (used in) operating activities (non-GAAP measure) (c) $ 1,391 $ 1,150 Purchases of property, plant and equipment (PPE) (475) (424) Manufactured PFAS products impact - removing related purchases of PPE 30 37 Adjusted purchases of PPE (non-GAAP measure) (c) $ (445) $ (387) Adjusted free cash flow (non-GAAP measure) (c) $ 946 $ 763 Adjusted net income attributable to 3M (non-GAAP measure) (b) $ 1,087 $ 1,512 Adjusted free cash flow conversion (non-GAAP measure) (c) 87 % 50 % (Dollars in billions) Full Year 2023 Forecast Net cash provided by (used in) operating activities* $5.8 to $6.3 Adjustments for special items* — Adjusted net cash provided by (used in) operating activities $5.8 to $6.3 Purchase of property, plant and equipment (PPE) ($1.5 to $1.8) Manufactured PFAS products impact — removing related purchases of PPE ~$0.2 Adjusted purchases of PPE (non-GAAP measure) (c) ($1.3 to $1.6) Adjusted free cash flow* (c) $4.2 to $5.0 Net income attributable to 3M* $4.7 to $5.0 Adjustments for special items* — Adjusted net income attributable to 3M* (b) $4.7 to $5.0 Adjusted free cash flow conversion* (c) 90% to 100% (c) 3M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) -- 10 of 13 -- Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures): Adjusted EBITDA (non-GAAP measure) (d) Adjusted EBITDA Margin (non- GAAP measure) (d) Three months ended March 31, Three months ended March 31, (Dollars in millions) 2023 2022 2023 2022 Safety and Industrial $ 696 $ 834 25.0 % 27.4 % Transportation and Electronics 361 532 21.2 % 26.3 % Health Care 510 601 25.3 % 28.2 % Consumer 217 256 18.2 % 19.6 % Corporate and Unallocated 29 94 Total Company $ 1,813 $ 2,317 23.6 % 27.2 % Three months ended March 31, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2023 2022 Adjusted net sales (non-GAAP measure) (b) $ 7,686 $ 8,509 Net income attributable to 3M 976 1,299 Add/(subtract): Net income/(loss) attributable to noncontrolling interest 5 4 (Income)/loss from unconsolidated subsidiaries, net of taxes (2) (2) Provision for income taxes 210 302 Other expense/(income): Interest (Income)/expense 83 105 Pension & OPEB non-service cost (benefit) (31) (67) Depreciation and amortization (DA) expense 466 459 Adjustments for special items: Net costs for significant litigation 43 250 Manufactured PFAS products impact: Remove manufactured PFAS products operating (income) loss (10) (16) Subtract PFAS-related amount included in DA above (29) (17) Divestiture costs 102 — Total special items 106 217 Adjusted EBITDA (non-GAAP measure) (d) $ 1,813 $ 2,317 Adjusted EBITDA margin (non-GAAP measure) (d) 23.6 % 27.2 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) -- 11 of 13 -- Adjusted EBITDA (non-GAAP measure) Three months ended March 31, 2023 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure) (b) $ 2,779 $ 1,705 $ 2,010 $ 1,192 $ — $ 7,686 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure) (b) $ 562 $ 284 $ 360 $ 179 $ (9) $ 1,376 Add/(subtract): Add depreciation and amortization (DA) expense 134 106 150 38 38 466 Subtract PFAS-related amount included in DA above — (29) — — — (29) Adjusted EBITDA (non-GAAP measure) (d) $ 696 $ 361 $ 510 $ 217 $ 29 $ 1,813 Adjusted EBITDA margin (non-GAAP measure) (d) 25.0 % 21.2 % 25.3 % 18.2 % 23.6 % Adjusted EBITDA (non-GAAP measure) Three months ended March 31, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure) (b) $ 3,051 $ 2,020 $ 2,128 $ 1,309 $ 1 $ 8,509 Business segment operating income (measure of segment operating performance), adjusted for special items (non-GAAP measure) (b) $ 690 $ 448 $ 445 $ 219 $ 73 $ 1,875 Add/(subtract): Add depreciation and amortization (DA) expense 144 101 156 37 21 459 Subtract PFAS-related amount included in DA above — (17) — — — (17) Adjusted EBITDA (non-GAAP measure) (d) $ 834 $ 532 $ 601 $ 256 $ 94 $ 2,317 Adjusted EBITDA margin (non-GAAP measure) (d) 27.4 % 26.3 % 28.2 % 19.6 % 27.2 % (d) 3M defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/ (income), depreciation and amortization expense, and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for special items that is then further adjusted for depreciation and amortization (DA) expense, net of the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales, adjusted for special items. Net debt (non-GAAP measure): Net Debt (non-GAAP measure) March 31, 2023 December 31, 2022 Total debt $ 15,960 $ 15,939 Less: Cash, cash equivalents and marketable securities 3,992 3,916 Net debt (non-GAAP measure) (e) $ 11,968 $ 12,023 (e) The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) -- 12 of 13 -- Description of special items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/ asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as corporate special items in Corporate and Unallocated. In the first quarter of 2023 and 2022, 3M made payments of approximately $73 million and $161 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. In the first quarter of 2023, 3M made payments of approximately $54 million associated with divestiture costs. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the first quarter of 2023 and 2022, 3M made payments of approximately $3 million and $1 million, respectively, associated with divestiture-related restructuring actions. Manufactured PFAS products: • These amounts relate to sales and estimates of income and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, and certain changes in working capital. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) -- 13 of 13 --